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A series of phosphorylcholine (PC) 1 binding myeloma proteins of BALB/c origin have 
been  described  and  characterized  by  several  laboratories  (1-4).  One  group  of these 
proteins, including among others T15, H8, and S107, has been shown to possess identical 
variable  region  antigenic  determinants  (idiotypes)  (2,  5)  as  well  as  identical  partial 
variable region light and heavy chain amino acid sequences (6). This group of proteins 
also demonstrates the same binding specificity for PC and various analogs (3). Other PC 
binding  proteins  have  been  identified  (M603, M167, Mfll,  and  W3207) which  have 
different idiotypes (2, 4), variable region amino acid sequences (6-10), and specificity (3, 
11). Studies in this laboratory and others (5,  11-14) have suggested that BALB/c mice 
immunized with PC-containing antigens respond by making antibodies predominantly of 
the T15 idiotype.  We have further shown that rabbit antisera specific  for an idiotypic 
determinant(s) in or associated with the combining site of the T15 group recognizes the 
same determinant in antibodies to PC elicited in BALB/c and 17 other mouse strains (5), 
suggesting  a  conservation  in  this  species  of at  least  one  binding  site  for  PC.  The 
characterization of a  PC-binding myeloma protein in CB  20 mice (BALB/c. B6  [IgCH]) 
with  structural,  functional,  and  idiotypic  characteristics  similar  to  T15  (15) further 
supports this contention. 
In an attempt to ascertain the  structural basis of the apparent binding site 
conservation we have begun to examine  the primary amino acid sequence of 
antibodies  to  PC  induced in  various  mouse strains.  This  system provides an 
opportunity to observe the  evolution of the  genes coding for these  antibodies 
among inbred strains of the same species and to assess the genetic mechanisms 
compatible with the  observed structures.  In this regard we report here initial 
studies on the characterization of anti-PC antibodies in A/J mice. 
Materials and Methods 
Production and Purification of  A/J Anti-PC Antibodies.  A/J mice were obtained at 6 wk of age 
from The Jackson  Laboratory, Bar Harbor, Maine. Beginning at 8 wk of age, and at biweekly 
intervals  thereafter,  45 mice received six intraperitoneal  injections of 108 heat-killed  (56°C, 30 
min) Streptococcus  pneumoniae str.  R36A (11). Mice were bled 4 and 6 days after each injection. 
Sera  obtained  after the  second injection all  had high  hemagglutinin  titers  and  were pooled. 
* Supported in part by National Institutes  of Health grant AI-12533. 
Abbreviations  used  ~n th~s paper:  GC, gas chromatography;  IEF,  isoelectric focusing; PC, 
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Antibodies with specificity for PC were isolated from a  PC-Sepharose column by affinity chroma- 
tography  (16).  A  total  of 21  mg of antibody  was  obtained from  92  ml  of serum;  each  mouse 
contributed on the  average  460  ~g of specific  antibody from  2  ml  of serum.  Isolated anti-PC 
antibodies were IgM by immunoelectrophoresis and by immunodiffusion with class-specific anti- 
sera. 
The BALB/c myeloma proteins T15,  H8,  W3207,  M603,  M511,  and M167  were purified from 
ascitic fluid as previously described (16). 
Isoelectr~c Focusing.  A/J  anti-PC  a~tibodies  and  myeloma  proteins  were  first  completely 
reduced with 0.2 M 2-mercaptoethanol in 7 M guanidine in Tris-HC1 buffer, pH 8.2 (2 h, 23°C) and 
alkylated with 0.4 M iodoacetamide ([14C]iodoacetamide, in some cases) (45 min, 4°C) (17).  Heavy 
(H) and light (L) chains, separated on Sephadex G-100 in 1 M  propionic acid-4.5 M  urea,  were 
analyzed by isoelectric focusing (IEF) in polyacrylamide gel slabs (15). After focusing gels were 
fixed in three changes of 5% TCA-5% sulfosalicylic acid and stained with Coomassie Brilliant Blue 
as described by Williamson (18). 
Quantitation of  Idiotypic Determinants.  Rabbit antibodies with specificity for the binding site 
of T15,  anti-T15s,  have been  described  (19).  Guinea  pig  antibodies having specificity  for  the 
binding site of M603,  W3207,  M511,  and M167  (i.e.  anti-M603s,  -W3207B, -M511B, -M167s)  were 
prepared in a similar fashion.  2 Each idiotypic antibody was completely specific for the respective 
myeloma protein; in both direct and indirect radioimmunoassays (see below) no cross-reactions 
were observed. Moreover, the reaction between each anti-idiotypic antibody and its corresponding 
myeloma protein was greater than 90% inhibited by PC. 
Quantitation of idiotypic determinants in A/J anti-PC antibodies was examined by solid-phase 
radioimmunoassay (TBA) as previously described (5). The amount of an idiotype in the A/J anti- 
PC pool was determined by comparing its inhibition to that of a  standard titration of myeloma 
protein for each of the five idiotype-anti-idiotype assay systems. The sensitivities of the assays 
ranged from 0.01 to 0.05 ~g/ml. 
Sequence Analysis.  20 mg of A/J anti-PC antibody was reduced under conditions described 
above but in the absence of guanidine. After separation on a  G-100 Sephadex column,  H  and L 
chain pools were dialyzed extensively against 1 M NaC1 and distilled water and lyophilized. 
Sequence determinations were  performed  on a  Beckman 890C  sequencer  (Beckman Instru- 
ments, Inc., Palo Alto, Calif.) as previously described (8).  Phenylthiohydantoin derivatives were 
identified  by  gas  chromatography  (GC)  (20),  thin-layer  chromatography  (TLC)  (21),  and  HI 
hydrolysis to the free amino acids (22). 
Results 
Isoelectric.Focusing  Patterns.  A  first assessment of the degree of heteroge- 
neity  in  A/J  anti-PC  antibodies  and  their  structural  similarities  to the  PC- 
binding myeloma proteins was determined by isoelectric  focusing of isolated L 
chains.  Fig.  1  shows  the  stained  L  chain  banding  patterns  of A/J  anti-PC 
antibody and compares them to those of five PC-binding myeloma proteins. The 
L chains of M167 and H8 are not shown separately since they focus in positions 
identical  to those of M511  and T15,  respectively.  T15 and H8 are  structurally 
identical (6) through the first complementarity region, whereas M511 and M167 
(7,  10) or M603 and W3207  (reference  6 and P.  Barstad,  personal communica- 
tion) have structurally similar but not identical L chains. The L chain of each of 
the myeloma proteins  appears in a  set of closely grouped bands focusing in a 
narrow  pH  range  of less  than  1  unit  which  is  indicative  of a  homogeneous 
polypeptide  (23).  The  L chains of M603 and W3207 co-focus, but they differ in 
that the staining intensity  of the bands is distributed differently.  The L chain 
banding  patterns  of A/J  anti-PC  by comparison to the  myeloma proteins  are 
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FIG.  1.  (a)  IEF  patterns of L  chains from A/J anti-PC antibodies and BALB/c anti-PC 
myeloma proteins. IEF was carried out in thin-layer polyacrylamide gel slabs in pH 5-9.5 
ampholytes. (b) Interpretation of (a) showing that A/J anti-PC antibodies are composed of L 
chain indistinguishable from M511  (. • .), M603 (--), and T15 (--). 
complex  and  range  from  pH  4.7  to  8.2.  However,  it  is  evident  that  bands 
corresponding in position to those of T15,  M603  (W3207),  and M511 (M167) are 
present. Because of their staining pattern, the middle set of  bands in A/J appear 
more closely related to M603 than W3207. No additional bands were seen in this 
preparation even when the amount of sample focused was increased fivefold. 
Our interpretation of the results, shown in the right hand panel of Fig. 1, is that 
A/J anti-PC antibodies contain at least three immunoglobulins whose L chains 
are nearly identical to those of liB, M603, and MSll (M167). Quantitation of each 
L chain type by determining the radioactivity in each band after IEF of 14C-A/J 
anti-PC L chains gave 28% H8-1ike L, 38% M603-1ike L, and 33% M511-(M167-)- 
like L. 
Determination ofIdiotypes.  A portion of the pool of antibodies from A/J mice 
was diluted to 136 ~g/ml and quantitated for idiotypic determinants characteris- 
tic  of the  available  PC-binding  myelomas.  As  shown  in  Table  I  each  anti- 
idiotypic antibody was specific for its corresponding myeloma protein and was 
capable of accurately recognizing that protein in a pool of idiotypes. Analysis of 
the A/J anti-PC antibody pool revealed the presence of idiotypic determinants 
associated with the binding site of  T15 and M511. Quantitative measurements of 
these two idiotypes indicated that each was present in about equal amounts and 
comprised approximately two-thirds of the antibody present in the pool. Binding 
site determinants of M167, M603, and W3207 were not detected in the pool, even 
though the assays were capable of measuring these idiotypes when present at a 
concentration of 10-50 ng/ml. Separate assays performed with additional guinea 
pig and rabbit antibody preparations to binding-site as well as nonbinding-site 
regions of W3207 (one antiserum), M603 (three antisera), and M167 (four anti- 
sera) failed to reveal the presence of immunoglobulin bearing W3207, M603, and 
M167 idiotypes (L. Claflin, unpublished data). Fttrthermore, attempts to detect 
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TABLE  I 
Concentration  of ldiotypes in AM Anti-PC Antibodies 
1297 
Antibody  Ig$ 
Idiotyplc determinant* 
T15s  M511s  M167s  M603s  W3207s 
pg/ml  I~glml  %  p.glml  %  i~g/ml  %  i~g/ml  %  pg/ml  % 
A/J anti-PC  136  41§  30§  52  38  <0.01  0  <0.05  0  <0 05  0 
T15, M511,  M603  33 each  34  34  29  29  <0.01  0  30  30  <0.05  0 
T15,  M167,  W3207  33 each  29  29  <0 01  0  32  32  0.05  0  37  37 
* Rabbit or guinea pig antibodies &rected to the binding sites ofT15  (anti-T15s), M511  (antl-M511s),  M167  (antl-M167s),  M603 
(anti-M603D,  and W3207  (anti-W32070)  were used. 
Immunoglobuhn (Ig) concentration of purified antibody. 
§ Concentrations  of anti-PC  antibody  (and percent of total  Ig) giving 50%  inhibition of binding of JzSI-myeloma  protein to the 
corresponding anti-i&otyplc antibody  was compared to a  standard curve obtained with the approprmte myeloma protein.  The 
error for each determination is +-15% of the calculated concentration.  Mean results of three separate experiments are shown. 
or M603 (anti-M167[~] or anti-M603tsl  vs. ~25I-A/J anti-PC antibody) were unsuc- 
cessful. 
H  Chain Sequence Determinations.  Isolated H chains were subjected to 36 
cycles of degradation. After analysis by GC and TLC the sequencer products 
from each  degradation cycle were hydrolyzed to their free  amino acids  and 
applied to an amino acid analyzer so that the spectrum of all amino acids at any 
given position could be observed in the same assay.  Quantitation of selected 
steps  from  the  H  chain  determination  are  presented  in  Table  II,  and  the 
sequence obtained is given in Table III. Significant heterogeneity was observed 
only at position 23 where Glx was found to be above background in addition to 
Ala. 
L  Chain  Sequence  Determination.  L  chains  were  analyzed as  described 
above  and the results are presented in Table  IV.  The  L  chain analysis was 
complicated by the fact that three different chains were being sequenced simul- 
taneously as is evidenced by the results. At positions one, two, and three only a 
single amino acid was obtained (Asp, Ile, Val). At position four, two amino acids 
were identified (Met and Ile)  in the ratio of approximately 2:1. At positions 
where two amino acids were identified in a  2:1 ratio the amino acid in higher 
concentration is listed twice for that position. After position 30 yields were no 
longer high enough to observe ratios as described above and the residues for 
positions 30 to 34 represent amino acids identified above background levels. 
Discussion 
Experiments  such  as  those described  above  are  essentially an  attempt to 
analyze the gene products of a specific immune response at the structural level 
both qualitatively and quantitatively. In this regard it is appropriate at this 
point to comment on the limits of the sequence data presented. Since heteroge- 
neity at any position in the sequence analysis may represent the occurrence of 
an additional gene, the methods and sensitivity of the techniques used for amino 
acid identification become limiting factors. It is important to point out that we 
are describing the results obtained from a pool of 45 mice rather than a  single 
mouse. Occasional amino acid interchanges, which may or may not be signifi- 
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TABLE  II 
Phenylthiohydantoin Yields from Heavy Chain 
Residue number  Amino acid  Total yield by GC 
nM 
2  Val  25.9 
4  Leu  28.4 
5  Val  27.0 
8  Gly  11.0 
11  Leu  22.0 
18  Leu  14.9 
23  Ala  6.3 
27  Phe  5.6 
32  Phe  4.7 
TABLE  III 
H Chain Variable Region Sequences of Anti-Phosphorylcholine Antibodies* 
A/J 
T15 
M603 
M167  __ 
M511 
1  10  20  30 
EVKLVZSGGGLVQPGGSLRLSC  ATSGFTFSB  FYMZ  (W) 
Z 
_A 
A 
V  A 
A 
* Sequences of T15,  M603,  and M167 are from Reference 6 and M511 from Reference 27. 
TABLE  IV 
L Chain Variable Region Sequences of Anti-Phosphorylcholine Antibodies* 
A/J 
1  10  20  30 
DIVMTQSPTFSLAVTASKKV  TI  SCTASZSL(Y)§SSK(H) 
M  SPSS  LS  TAGZ  K  TM  KS  Z  L 
I  BZLS  NP  SS GZ  S  SL  S  K  L 
T15  DIVMTQS  PTF  LAVTASKKV  TI  SCTASZSL  Y 
M603  SS  LS--S---GZ  R----M  KS--L 
M16711  __I~BZLS  NP.__SGZS__SI  ,RS__K  .  L 
M511  --I  BZLS  KP.  .SGZ  S--SI-- 
B  K G  (B) 
B  G 
SSK  H 
B--G  ,B 
YKB  G 
* Sequences of T15  and M603  are from Reference 6,  M167  from Reference 10,  and M511  from 
Reference 7. 
Ala was observed at this position by GC but not TLC and may be an artifact. 
§ Amino acids in parentheses are tentatively identified. 
H Positions 11 and 22 in M167 have previously been reported as Asp (D) and Thr (T) respectively 
(28). We have found these positions to be Ash (N) and Set (S) (10). STUART  RUDIKOFF  AND  J.  LATHAM  CLAFLIN  1299 
paper are those detected within these limitations and must be regarded as the 
major sequences in  the  response  while  not excluding  the  possibility of other 
structures at undetectable levels. For experiments  involving induced antibod- 
ies, such as these, TLC is used in our laboratory only qualitatively to differen- 
tiate  acidic  and  amide  residues as the results  are difficult to quantitate.  All 
positions in these sequencer runs were initially analyzed by GC and results from 
the H chain are given in Table II. As may be seen at position 32 the total yield of 
Phe is 4.7 nM. 8% of the total sample was used for GC analysis or approximately 
0.4 nM of Phe.  This amount of material  is close to the confidence limits of the 
assay. Thus, any other amino acids present at 50% or less of the major residue 
will likely be undetected.  Heterogeneity in the early portion of the sequencer 
runs where yields are considerably higher would be detected at roughly the 10% 
level.  Since only about one-half of the amino acid derivatives are adequately 
identified by GC the sequencer products at all positions were hydrolyzed to their 
free amino acids (22) and subjected to amino acid analysis. This method of identi- 
fication while having about the same sensitivity as GC permits the observation 
of the levels of almost all amino acids in a  single assay. 
The present results provide three pieces of evidence which strongly imply that 
A/J  and  BALB/c  mice  have  identical  or  nearly  identical  genes  coding  for 
antibodies to PC.  Based on (a) L chain IEF patterns,  (b) idiotypes, and  (c) N- 
terminal  structure  of H  and  L  chains,  A/J  anti-PC  antibodies  are  strikingly 
similar to three BALB/c myeloma proteins that bind PC (T15, M511, M603).  The 
results of the IEF experiments show that the L chains from antibodies produced 
to PC in A/J mice co-focus with  L  chains  from BALB/c PC-binding  myeloma 
proteins  (T15  or H8,  M511 or M167,  M603  or W3207).  Because this procedure 
measures principally charge differences one cannot assume that by this criterion 
alone each L chain type represents a single sequence (e.g. M511 and M167 have 
been reported to differ at a single position in their amino terminal 23 residues (7, 
10,  26)) or that each L chain is associated with only a  single H  chain.  It does, 
however, define limits in L chain heterogeneity that exist in the response and 
shows that the L chains produced in A/J anti-PC antibody are indistinguishable 
in  charge  composition  from  the  L  chains  of PC-binding  immunoglobulins  of 
BALB/c origin. Idiotypic analysis, however, is highly discriminatory and capa- 
ble of recognizing  what must be small  differences in structure.  Indeed,  in the 
present work there is a remarkable correlation between idiotype (as defined by 
these  antisera)  and  structure.  Idiotype analysis  when  correlated  with  the  L 
chain percentage confirms the contention (5,  15) that the L chains in A/J anti- 
PC  antibody,  which  have  the  same  pI  as  T15  L,  are  derived  from  T15-1ike 
molecules.  Furthermore,  the distinction between M511-  or M167-1ike antibody 
in  the  A/J  anti-PC  pool  is  readily  made.  Likewise  A/J  immunoglobulin(s) 
having  an  M603-1ike  L  chain  is  not  totally  like  either  M603  or  W3207  even 
though  its L chains  have the same pI and are similar in structure to M603 L 
chains (see below). The failure to find the M603 idiotype in the A/J pool suggests 
that this L chain may be associated with an H chain other than that found in the 
BALB/c protein.  However, in separate experiments  we have found that  every 
mouse strain tested to date produces some antibody with L chains that cofocus 
with M6032 and that these M603-1ike antibodies from all strains share idiotypic 
determinants  (J. L. Claflin,  unpublished results). 1300  EQUIVALENT  CLONOTYPES  IN  TWO  MOUSE  STRAINS 
Probably the most compelling data for the presence of identical or very similar 
genes in the two strains is the amino acid sequence analysis. When the sequence 
of the  A/J  H  chain  pool is compared to the four BALB/c H  chains from PC- 
binding proteins (Table III) it can be seen that both the framework (positions 1- 
29) and first complementarity regions (positions 30-35) are essentially identical 
in all of the proteins with one exception. Val found at position four in M167 is not 
seen in the A/J pool. Position 23 in the A/J chains was found to contain both Ala 
and Glx while Ala is the only amino acid at this position in the BALB/c chains. 
Complete variable region sequences of the H  chains from the BALB/c proteins 
have shown that T15, M603, M167 (8, 9), and M511 (27) have differences after the 
first  complementarity  region.  Thus,  it  can  not  be  determined  at  this  time 
whether the A/J H chains are composed of a single molecular species or several 
as in the BALB/c proteins. Kluskens et al. (28), in an analysis of the H chains of 
BALB/c anti-PC  antibody,  found  a  single  sequence for the  first  20  residues, 
though,  in this case, only the T15 idiotype was detected. 
The L  chain  analysis while complicated by the simultaneous  sequencing of 
three  chains  provides  essentially  the  same  results.  By  comparing  the  A/J 
sequences to the published BALB/c L chains (6, 7, 10) (Table IV) it can be seen 
that in A/J only a  single amino acid was identified at positions one, two, and 
three (Asp, Ile, Val). The three BALB/c chains also all have Asp, Ile, and Val at 
the first three positions. Position four in the A/J sequence contained two amino 
acids, Met and Ile, in the ratio of 2:1. From the BALB/c sequences it can be seen 
that both T15 and M603 have Met at this position, whereas M511 or M167 has 
Ile. Thus the ratio for two Met:one Ile in the A/J sequence is consistent with the 
presence of three L chains identical to those of the BALB/c proteins. This type of 
analysis can be made for the first 30 positions of the L chain.  At all positions 
where the three BALB/c chains have the same amino acid (1-3, 5, 6, 13, 19, 21, 
22, 24, 26, 27), that amino acid alone was also found in the A/J sequence. At the 
other positions the amino acids present in the BALB/c sequences were likewise 
found  in  the  A/J  with  the  following exceptions.  In  the  A/J  chains  Ala  was 
detected at position 10 by GC but not TLC and, thus, may be an artifact. Position 
18 appears to contain two Lys and one Ser residue, which suggests a substitution 
of Lys in the A/J chains for Arg found in M603. Position 21 contained Ile and Leu 
in addition to Met, which indicates an interchange to Leu for the Ile in either the 
T15 or M511 sequence. Arg at position 24 in the M167 chain was not identified 
but may be a technical problem as Arg in low yields is very difficult to analyze. 
Again,  this analysis includes both the first framework portion of the L  chain 
(positions 1-26) and part of the first complementarity region  (from 27 on). The 
discrepancy between idiotyping and sequence analysis for M511- and M167-1ike 
antibody in A/J may be minor.  M511 and M167 differ by a single amino acid in 
the first 23 residues which can be explained by a single base change. Thus, these 
two L chains may be extremely similar but associated with different H  chains 
accounting for the idiotype differences. 
The finding that  essentially identical  H  and L chains are found in anti-PC 
antibodies from both A/J and  BALB/c strains  of mice implies that  the genes 
coding  for  these  structures  are  likewise  very  similar  if not  identical.  This 
observation  is  striking  in  that  A/J  and  BALB/c differ  considerably  in  their STUART  RUDIKOFF  AND  J,  LATHAM  CLAFLIN  1301 
genetic makeup, and most importantly for these studies, at the H chain allotype 
locus. In terms of genetic mechanisms, it appears that for two unrelated strains 
to express the same primary sequences in an antibody response the genes coding 
for the  respective  H  and  L  chains  must  be contained  in  the  germ  line.  The 
likelihood  of identical  structures  arising  somatically  by parallel  mutation  is 
extremely small. Several investigators have suggested the possibility that com- 
plementarity regions are coded for by an additional gene or episome which is 
inserted  into a  second gene coding for the framework portion of the  variable 
region  (29,  30).  This  mechanism  also appears  unlikely to be involved in  the 
system described here  for the  following reasons.  For the  framework  and  the 
complementarity  regions  to  be  identical  in  the  two  strains  but  encoded  by 
different genes, would require that identical parallel evolution of the two genes 
had occurred in each strain.  Since the same complementarity regions appear to 
be associated with the same framework sequences in both strains, an insertional 
mechanism  would further require that  selection also take place at the frame- 
work level so that a specific framework sequence is always paired with the same 
complementarity region.  Since the H chain sequence data extend only through 
the first complementarity region it is conceivable that the remainder of the H 
chains may be quite different from their BALB/c counterparts which would then 
make the data compatible with an insertional mechanism.  The same point can 
be raised for the L chains.  However, in this case the isoelectric focusing results 
further suggest that the L chains will be very similar to those in the BALB/c 
proteins. Furthermore, the idiotypic analysis again supports the contention that 
the uncharacterized portions of the variable regions (at least in the case of the 
T15 and MSll-like proteins) will again be very similar to those of the BALB]c 
proteins.  It seems to us the most plausible explanation  of the data is that the 
framework and  complementarity regions involved in the anti-PC  immune re- 
sponse have coevolved and  are coded for by a  single gene.  Selective pressure 
would then account for the maintenance  of these genes in the two strains. 
An  important  difference between these  studies  on  induced  antibodies  and 
those  from  other  laboratories  is  our  finding  of similarities  not just  within 
genetically identical individuals but between genetically unrelated members of 
a species. Capra et al. (31) and Freidenson et al. (32) have found that antibodies 
of defined idiotype from pooled serum or individual mice of a single strain (A/J) 
raised  to  an  arsonate  hapten  are  homogeneous  in  both  their  first  H  chain 
complementarity  and  framework  regions.  Cebra  et  al.  (33)  found  that  the 
sequences  in  the  first  83  residues  of the  H  chain  variable  region  in  three 
different antibodies to haptens from strain 13 guinea pigs were either unique or 
of restricted variability compared to normal immunoglobulin. It will be of great 
interest  to  see if the  same  sequences  from  anti-arsonate  antibodies  (31,  32) 
described  in  the  mouse,  or from  anti-arsonate,  anti-dinitrophenyl,  and  anti- 
trimethylammonium antibodies (33) identified in the guinea pig can be found in 
different strains of mice or guinea pigs, respectively. In point of fact, groups of 
human myeloma proteins (which are obviously obtained from individuals in an 
outbred population)  show remarkable  similarities  to the  anti-PC  system  de- 
scribed above. A series of human cold agglutinins were found to fall into three 
major groups  defined by shared  idiotypic specificities  (34).  A  second group of 1302  EQUIVALENT  CLONOTYPES  IN  TWO  MOUSE  STRAINS 
human proteins with anti-gamma globulin activity has also been characterized 
(35).  Two groups of these anti-gamma  globulin proteins have been reported to 
share idiotypic specificities,  although  each protein has been shown to possess 
individual antigenic determinants.  The complete H chain variable region amino 
acid sequence from two of the anti-gamma globulin proteins, Lay and Pom, has 
been determined by Capra and Kehoe (36). Only eight differences were found in 
the entire variable regions of which seven were from parts of the molecule which 
do not participate in antigen binding. The similarity of these proteins is remark- 
able considering their source and points out a high correlation between idiotypy 
(albeit crossreacting in this case) and primary structure.  Thus,  in view of our 
findings and those in humans one should anticipate considerable conservation of 
genetic information within a species. We are continuing to test this hypothesis 
by raising  anti-PC  antibodies in several other mouse strains  as well as other 
species to  see if the  same  set  of genes  can  be identified  and  their  products 
characterized. 
Summary 
Analysis of A/J antibody to phosphorylcholine (PC) revealed a striking degree 
of similarity to PC-binding myeloma proteins of BALB/c origin. By quantitative 
idiotypic analysis  A/J  anti-PC  antibody  was  composed of antibodies  bearing 
binding site idiotypic determinants indistinguishable from two different BALB/c 
myeloma proteins,  T15  and  M511.  Idiotypic determinants  of three  other PC- 
binding proteins, W3207, M167, and M603 were not detected. Isoelectric focusing 
of the light chains verified the presence of antibodies similar to T15 and M511 
and  indicated  the  presence  of a  third  antibody  whose light  chains  had  a  pI 
identical to that of M603. When the sequence of A/J heavy chains was compared 
to  the  heavy chains  of T15,  M511,  and  M603,  both the  framework  and  first 
complementarity regions were identical in all cases. Sequences analysis of the 
light  chains  through  part  of the  first  complementarity  region  revealed three 
chains, one similar to each of the myeloma proteins T15, M603, and M167-M511. 
The  latter  two  sequences  differ  by only  a  single  amino  acid  (a  single  base 
substitution) in the first 23 residues, suggesting that the two light chains may be 
very similar if not identical. 
Thus, BALB/c and A/J mice which differ genetically at multiple loci including 
the heavy chain allotype complex locus show a remarkable preservation of their 
anti-PC  antibodies.  These results indicate that the genes encoding these anti- 
bodies are contained in the germ line. 
Received for publication 12 July 1976. 
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